Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic

AIM: We aimed to develop a decision aid (DA) for individuals with anxiety disorders who consider tapering benzodiazepine (BZD) anxiolytics, and if tapering, tapering BZD anxiolytics with or without cognitive behavioral therapy (CBT) for anxiety. We also assessed its acceptability among stakeholders....

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Yumi, Takaesu, Yoshikazu, Inada, Ken, Yamada, Hiroki, Murao, Tomohiko, Kikuchi, Toshiaki, Takeshima, Masahiro, Tani, Masayuki, Mishima, Kazuo, Otsubo, Tempei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213963/
https://www.ncbi.nlm.nih.gov/pubmed/37252154
http://dx.doi.org/10.3389/fpsyt.2023.1083568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213963/
https://www.ncbi.nlm.nih.gov/pubmed/37252154
http://dx.doi.org/10.3389/fpsyt.2023.1083568

Ejemplares similares